Intol, Jessa Mae C.
HRN: 21-27-14 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/26/2023
CEFUROXIME 1.5GM (VIAL)
06/26/2023
06/27/2023
IV
1.5gms
Q8hrs X 3 Doses
S/P LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes